TRS vs ESAB

For growth investors, ESAB Corporation (ESAB) is the stronger pick with 3.

7% revenue growth year-over-year, versus -30. 2% for TriMas Corporation (TRS). TriMas Corporation (TRS) offers the better valuation at 14. 1x trailing P/E (26. 5x forward), making it the more compelling value choice. Analysts rate TriMas Corporation (TRS) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, TriMas Corporation (TRS) is the cheapest at 14.

1x versus ESAB Corporation at 27. 3x. On forward P/E, ESAB Corporation is actually cheaper at 17. 6x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, ESAB Corporation (ESAB) delivered a total return of +105.

4%, compared to +26. 5% for TriMas Corporation (TRS). Over 10 years, the gap is even starker: TRS returned +148. 1% versus ESAB's +105. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), TriMas Corporation (TRS) is the lower-risk stock at 1.

04β versus ESAB Corporation's 1. 24β — meaning ESAB is approximately 20% more volatile than TRS relative to the S&P 500. On balance sheet safety, ESAB Corporation (ESAB) carries a lower debt/equity ratio of 65% versus 72% for TriMas Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), ESAB Corporation (ESAB) is pulling ahead at 3.

7% versus -30. 2% for TriMas Corporation (TRS). On earnings-per-share growth, the picture is similar: TriMas Corporation grew EPS 400. 0% year-over-year, compared to -13. 7% for ESAB Corporation. Over a 3-year CAGR, ESAB leads at 3. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

TriMas Corporation (TRS) is the more profitable company, earning 18.

6% net margin versus 8. 0% for ESAB Corporation — meaning it keeps 18. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ESAB leads at 17. 3% versus 2. 2% for TRS. At the gross margin level — before operating expenses — ESAB leads at 35. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, ESAB Corporation (ESAB) trades at 17.

6x forward P/E versus 26. 5x for TriMas Corporation — 8. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ESAB: 44. 5% to $146. 67.

All stocks in this comparison pay dividends.

TriMas Corporation (TRS) offers the highest yield at 0. 4%, versus 0. 4% for ESAB Corporation (ESAB).

For long-horizon retirement investors, TriMas Corporation (TRS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

04), +148. 1% 10Y return). Both have compounded well over 10 years (TRS: +148. 1%, ESAB: +105. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (TRS (Consumer Cyclical) and ESAB (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: TRS is a small-cap deep-value stock; ESAB is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.